02162 KEYMED BIO-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 3.30X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 10.9% | Net Margin | N/A |
| Total Debt/Equity | 30.4% | Return on Equity | N/A |
| Price/Book | 6.23X | Return on Assets | N/A |
| (HKD 58.600) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | -547.96 | -396.08 | -345.46 | -4,754.57 | -971.49 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -38.3 | -14.7 | +92.7 | -389.4 | -418.8 |
| Earnings Per Share (HKD) | -2.092 | -1.515 | -1.323 | -29.559 | -14.479 |
| Earnings Per Share Growth (%) | -38.0 | -14.5 | +95.5 | -104.2 | +99.9 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 9.408 | 11.767 | 13.388 | 15.963 | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 428.124 | 354.095 | +20.9 | 100.063 |
| Operating Result | -503.391 | -351.44 | +43.2 | -293.886 |
| Associates | -5.256 | -4.748 | +10.7 | -9.711 |
| Profit Before Taxation | -508.647 | -356.188 | +42.8 | -303.597 |
| Taxation | 6.26 | 1.597 | +292.0 | 0 |
| Profit /( Loss) After Taxation | -514.907 | -357.785 | +43.9 | -303.597 |
| Minority Interests | 0.334 | 1.572 | -78.8 | 4.518 |
| Net Profit | -515.241 | -359.357 | +43.4 | -308.115 |
| Earnings Per Share () | -2.0919 | -1.5154 | +38.0 | -1.3230 |
| Announcement Date | 2025-03-24 | 2024-03-26 | NA | 2023-03-17 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
